U.S. drug manufacturers with products in late-stage clinical trials and on the path to FDA approval may be overlooking an important consideration: preparing for serialization. Starting this November, ...
Recent research shows that the pharmaceutical industry is intensifying efforts to combat counterfeit drugs, which account for up to 30% of medicines sold globally. In a major step toward securing ...
Pharmaceutical counterfeiting is on the rise – and a growing health and safety issue with deep consequences for consumers and manufacturers alike. A number of factors contribute to counterfeiting, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results